Prospective observational study of (177)Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity

PURPOSE: Peptide receptor radionuclide therapy in patients with neuroendocrine tumours has yielded promising results. This prospective study investigated the feasibility of dosimetry of the kidneys and bone marrow during therapy and its impact on efficacy and outcome. METHODS: The study group compri...

Descripción completa

Detalles Bibliográficos
Autores principales: Garske-Román, Ulrike, Sandström, Mattias, Fröss Baron, Katarzyna, Lundin, Lars, Hellman, Per, Welin, Staffan, Johansson, Silvia, Khan, Tanweera, Lundqvist, Hans, Eriksson, Barbro, Sundin, Anders, Granberg, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915504/
https://www.ncbi.nlm.nih.gov/pubmed/29497803
http://dx.doi.org/10.1007/s00259-018-3945-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915504/
https://www.ncbi.nlm.nih.gov/pubmed/29497803
http://dx.doi.org/10.1007/s00259-018-3945-z

Ejemplares similares